ASLAN Pharmaceuticals (ASLN) Falls 25% Following Phase 1 Data of ASLAN004

September 27, 2021 6:26 AM EDT Send to a Friend

ASLAN Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

ASLAN Pharmaceuticals (ASLN) Falls 25% Following Phase 1 Data of ASLAN004

Member Login

Free News Feed